MESOBLAST LIMITED
Who is MESOBLAST LIMITED?
Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant, unmet medical needs. The Company's Phase 3 off-the-shelf mesenchymal lineage cell product candidates are: • RYONCIL™ (remes...See more
Industry & Specialities
Others
Countries of Operation
Australia Singapore
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
51-200 Employees
Year Founded:
2004 (22 years)
Address:
LEVEL 38, 55 COLLINS ST; MELBOURNE, VIC 3000, AU
Employees by Department
- IT / Product (9)
- Sales (1)
- The Rest (20)
- Total (30)
Key Decision Makers
Andrew Chaponnel
Interim CFO
Normand Davidzon
Vice President, Engineering Technology
Dina Pratt
Head Of Human Resources (Global)
Dina Pratt
Head Of Human Resources
Insight
Signals
At a glance- Operates in multiple countries
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
6employees
Non-managers
12employees
Financials
HIGH
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has MESOBLAST LIMITED been operating for?
- What is the funding status of MESOBLAST LIMITED?
- Where is MESOBLAST LIMITED's headquarter?
- What MESOBLAST LIMITED's spending power?
- Does MESOBLAST LIMITED have a presence in the domain it operates in?